Defence Therapeutics's total assets for Q2 2024 were C$403.03K, a decrease of -5.10% from the previous quarter. DTCFF total liabilities were C$3.86M for the fiscal quarter, a -15.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.